Diana Brixner
0000-0001-6637-6359
Publication & Citation Trends
Publications
0 total
Optimization of oncology biomarker testing in managed care: Best practices and consensus recommendations from an AMCP Market Insights program.
Cited by 1
Semantic Scholar
AMCP real-world evidence standards: Overcoming barriers to using real-world evidence in US payer decision-making.
Cited by 0
Semantic Scholar
Modeling the population health impact of incorporating a multi-cancer early detection (MCED) test to existing cancer screening among immunocompromised individuals
Cited by 1
Semantic Scholar
The impact of a statewide insulin copay cap policy for insured patients with diabetes in Utah. OA
Cited by 5
Semantic Scholar
Abstract PO1-16-07: Patient Characteristics and Treatment Sequencing Among HER2-low Metastatic Breast Cancer Patients with Rapid vs. Delayed Progression on First-line Endocrine Therapy
Cited by 0
Semantic Scholar
RWD43 Comparison of All-Cause Healthcare Resource Utilization Rates between Patients with Type 2 Diabetes Who Use a Digital Diabetes Solution Versus Non-Users: A 12-Month Retrospective Cohort Study
Cited by 0
Semantic Scholar
Caregiver survey in glioblastoma focused on cognitive dysfunction: development and results from a multicenter study.
Cited by 1
Semantic Scholar
Research Topics
Health Systems, Economic Evaluations, Quality of Life
(48)
Diabetes Treatment and Management
(35)
Diabetes Management and Research
(29)
Medication Adherence and Compliance
(27)
Pharmaceutical Economics and Policy
(19)
Affiliations
Novartis (Switzerland)
St. Jude Children's Research Hospital
Pfizer (United States)
GTx (United States)
Wilmington University